2023 Q1 Form 10-Q Financial Statement

#000147793223004157 Filed on June 01, 2023

View on sec.gov

Income Statement

Concept 2023 Q1 2022 Q2 2022 Q1
Revenue $30.59K $0.00
YoY Change
Cost Of Revenue
YoY Change
Gross Profit
YoY Change
Gross Profit Margin
Selling, General & Admin
YoY Change
% of Gross Profit
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization
YoY Change
% of Gross Profit
Operating Expenses $59.64K $47.14K
YoY Change 26.51%
Operating Profit -$29.05K -$47.14K
YoY Change -38.38%
Interest Expense
YoY Change
% of Operating Profit
Other Income/Expense, Net $7.029K $10.23K
YoY Change -31.32%
Pretax Income -$29.05K -$47.14K
YoY Change -38.38%
Income Tax $0.00 $0.00
% Of Pretax Income
Net Earnings -$27.09K -$47.14K
YoY Change -42.55%
Net Earnings / Revenue -88.54%
Basic Earnings Per Share
Diluted Earnings Per Share
COMMON SHARES
Basic Shares Outstanding 2.096B shares
Diluted Shares Outstanding

Balance Sheet

Concept 2023 Q1 2022 Q2 2022 Q1
SHORT-TERM ASSETS
Cash & Short-Term Investments
YoY Change
Cash & Equivalents $412.00 $312.00 $312.00
Short-Term Investments
Other Short-Term Assets
YoY Change
Inventory $0.00
Prepaid Expenses
Receivables $50.00K $50.00K
Other Receivables
Total Short-Term Assets $50.41K $50.31K
YoY Change 16025.64%
LONG-TERM ASSETS
Property, Plant & Equipment
YoY Change
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets $836.00 $836.00
YoY Change 0.0%
Total Long-Term Assets $836.00 $836.00
YoY Change 0.0%
TOTAL ASSETS
Total Short-Term Assets $50.41K $50.31K
Total Long-Term Assets $836.00 $836.00
Total Assets $51.25K $51.15K
YoY Change 4355.4%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $472.5K
YoY Change 0.0%
Accrued Expenses $354.5K
YoY Change 0.0%
Deferred Revenue
YoY Change
Short-Term Debt
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $1.495M $2.086M
YoY Change 18.84%
LONG-TERM LIABILITIES
Long-Term Debt
YoY Change
Other Long-Term Liabilities
YoY Change
Total Long-Term Liabilities
YoY Change
TOTAL LIABILITIES
Total Short-Term Liabilities $1.495M $2.086M
Total Long-Term Liabilities
Total Liabilities
YoY Change
SHAREHOLDERS EQUITY
Retained Earnings -$2.735M -$3.278M
YoY Change 8.7%
Common Stock $209.6K $209.6K
YoY Change 0.0%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity -$1.444M -$2.035M -$1.206M
YoY Change
Total Liabilities & Shareholders Equity $51.25K $51.15K
YoY Change 4355.4%

Cashflow Statement

Concept 2023 Q1 2022 Q2 2022 Q1
OPERATING ACTIVITIES
Net Income -$27.09K -$47.14K
YoY Change -42.55%
Depreciation, Depletion And Amortization
YoY Change
Cash From Operating Activities
YoY Change
INVESTING ACTIVITIES
Capital Expenditures
YoY Change
Acquisitions
YoY Change
Other Investing Activities
YoY Change
Cash From Investing Activities
YoY Change
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities
YoY Change
NET CHANGE
Cash From Operating Activities
Cash From Investing Activities
Cash From Financing Activities
Net Change In Cash
YoY Change
FREE CASH FLOW
Cash From Operating Activities
Capital Expenditures
Free Cash Flow
YoY Change

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2018Q1 us-gaap Treasury Stock Shares Acquired
TreasuryStockSharesAcquired
172800000 shares
us-gaap Business Combination Consideration Transferred1
BusinessCombinationConsiderationTransferred1
57107 usd
us-gaap Stockholders Equity Other
StockholdersEquityOther
1444241 usd
CY2022Q1 us-gaap Derivative Forward Exchange Rate1
DerivativeForwardExchangeRate1
1.37 pure
CY2023Q1 us-gaap Derivative Average Forward Exchange Rate1
DerivativeAverageForwardExchangeRate1
1.21 pure
CY2022Q1 us-gaap Derivative Average Forward Exchange Rate1
DerivativeAverageForwardExchangeRate1
1.31 pure
us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.50 pure
CY2023Q1 us-gaap Accumulated Other Comprehensive Income Loss Foreign Currency Translation Adjustment Net Of Tax
AccumulatedOtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentNetOfTax
52276 usd
CY2023Q1 us-gaap Accrued Professional Fees Current
AccruedProfessionalFeesCurrent
31000 usd
CY2022Q2 us-gaap Accrued Professional Fees Current
AccruedProfessionalFeesCurrent
31000 usd
CY2023Q1 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
83121 usd
CY2022Q2 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
70916 usd
CY2023Q1 us-gaap Accrued Liabilities Current And Noncurrent
AccruedLiabilitiesCurrentAndNoncurrent
114121 usd
CY2022Q2 us-gaap Accrued Liabilities Current And Noncurrent
AccruedLiabilitiesCurrentAndNoncurrent
101916 usd
CY2023Q1 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
5000000000 shares
CY2023Q1 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
20000000 shares
CY2023Q1 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.0001
us-gaap Common Stock Voting Rights
CommonStockVotingRights
Each outstanding share of common stock entitles the holder to one vote per share on all matters submitted to a stockholder vote
CY2023Q1 us-gaap Due To Related Parties Current And Noncurrent
DueToRelatedPartiesCurrentAndNoncurrent
1381368 usd
CY2022Q2 us-gaap Due To Related Parties Current And Noncurrent
DueToRelatedPartiesCurrentAndNoncurrent
1258676 usd
CY2021 us-gaap Related Party Transaction Expenses From Transactions With Related Party
RelatedPartyTransactionExpensesFromTransactionsWithRelatedParty
262116 usd
us-gaap Debt Instrument Decrease Forgiveness
DebtInstrumentDecreaseForgiveness
262116 usd
us-gaap Sale Of Stock Description Of Transaction
SaleOfStockDescriptionOfTransaction
Both parties agreed that the date for the first closing ($500,000) will take place by bank transfer no later than mid-March 2019. The following payments will be 90 days later (i.e. on or before May 31, 20219) as follows: $2,250,000 by way of bank transfer and $2,250,000 by the issue of 2,250,000 new shares of common stock of the Company. As of the date of this report the transaction had not yet closed and the Company does not anticipate this will close
dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
DE
us-gaap Labor And Related Expense
LaborAndRelatedExpense
22414 usd
us-gaap Labor And Related Expense
LaborAndRelatedExpense
69239 usd
CY2023Q1 us-gaap Other Expenses
OtherExpenses
7029 usd
CY2022Q1 us-gaap Other Expenses
OtherExpenses
10234 usd
us-gaap Other Expenses
OtherExpenses
10234 usd
us-gaap Other Expenses
OtherExpenses
43924 usd
CY2023Q1 us-gaap Legal Fees
LegalFees
5000 usd
CY2022Q1 us-gaap Legal Fees
LegalFees
0 usd
us-gaap Legal Fees
LegalFees
101500 usd
us-gaap Legal Fees
LegalFees
39758 usd
CY2023Q1 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
35408 usd
CY2022Q1 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
7270 usd
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
69886 usd
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
54614 usd
CY2023Q1 us-gaap Operating Expenses
OperatingExpenses
59642 usd
CY2022Q1 us-gaap Operating Expenses
OperatingExpenses
47144 usd
us-gaap Operating Expenses
OperatingExpenses
223268 usd
us-gaap Operating Expenses
OperatingExpenses
207535 usd
CY2023Q1 us-gaap Operating Income Loss
OperatingIncomeLoss
-29050 usd
CY2022Q1 us-gaap Operating Income Loss
OperatingIncomeLoss
-47144 usd
dei Entity Central Index Key
EntityCentralIndexKey
0001683252
dei Amendment Flag
AmendmentFlag
false
dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--06-30
dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q3
dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2023
dei Document Quarterly Report
DocumentQuarterlyReport
true
dei Document Transition Report
DocumentTransitionReport
false
CY2022Q2 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
2095872947 shares
CY2023Q1 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
2095872947 shares
CY2022Q2 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
2095872947 shares
CY2022Q2 us-gaap Treasury Stock Deferred Employee Stock Ownership Plan
TreasuryStockDeferredEmployeeStockOwnershipPlan
50000 usd
CY2023Q1 us-gaap Allowance For Doubtful Accounts Receivable
AllowanceForDoubtfulAccountsReceivable
0 usd
dei Document Type
DocumentType
10-Q
dei Document Period End Date
DocumentPeriodEndDate
2023-03-31
dei Entity File Number
EntityFileNumber
000-55688
dei Entity Registrant Name
EntityRegistrantName
Token Communities Ltd.
dei Entity Tax Identification Number
EntityTaxIdentificationNumber
81-3709511
dei Entity Address Address Line1
EntityAddressAddressLine1
4802 Lena Road
dei Entity Address Address Line2
EntityAddressAddressLine2
Unit 105
dei Entity Address City Or Town
EntityAddressCityOrTown
Bradenton
dei Entity Address State Or Province
EntityAddressStateOrProvince
FL
dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
34211
dei City Area Code
CityAreaCode
631
dei Local Phone Number
LocalPhoneNumber
397-1111
dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
dei Entity Filer Category
EntityFilerCategory
Non-accelerated Filer
dei Entity Small Business
EntitySmallBusiness
true
dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
false
dei Entity Shell Company
EntityShellCompany
false
CY2023Q1 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
2095872947 shares
CY2023Q1 us-gaap Cash Equivalents At Carrying Value
CashEquivalentsAtCarryingValue
412 usd
CY2022Q2 us-gaap Cash Equivalents At Carrying Value
CashEquivalentsAtCarryingValue
312 usd
CY2023Q1 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
50000 usd
CY2022Q2 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
50000 usd
CY2023Q1 us-gaap Assets Current
AssetsCurrent
50412 usd
CY2022Q2 us-gaap Assets Current
AssetsCurrent
50312 usd
CY2023Q1 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
836 usd
CY2022Q2 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
836 usd
CY2023Q1 us-gaap Assets
Assets
51248 usd
CY2022Q2 us-gaap Assets
Assets
51148 usd
CY2023Q1 us-gaap Accounts Payable And Accrued Liabilities Current
AccountsPayableAndAccruedLiabilitiesCurrent
114121 usd
CY2022Q2 us-gaap Accounts Payable And Accrued Liabilities Current
AccountsPayableAndAccruedLiabilitiesCurrent
101916 usd
CY2023Q1 us-gaap Due To Related Parties Current
DueToRelatedPartiesCurrent
1381368 usd
CY2022Q2 us-gaap Due To Related Parties Current
DueToRelatedPartiesCurrent
1258676 usd
CY2023Q1 us-gaap Liabilities Current
LiabilitiesCurrent
1495489 usd
CY2022Q2 us-gaap Liabilities Current
LiabilitiesCurrent
1360592 usd
CY2023Q1 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
2095872947 shares
CY2023Q1 us-gaap Common Stock Value
CommonStockValue
209587 usd
CY2022Q2 us-gaap Common Stock Value
CommonStockValue
209587 usd
CY2023Q1 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
1039610 usd
CY2022Q2 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
1039610 usd
CY2023Q1 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
52276 usd
CY2022Q2 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-5603 usd
CY2023Q1 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-2734749 usd
CY2022Q2 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-2553038 usd
CY2023Q1 us-gaap Minority Interest
MinorityInterest
-1965 usd
CY2022Q2 us-gaap Minority Interest
MinorityInterest
0 usd
CY2023Q1 us-gaap Stockholders Equity
StockholdersEquity
-1444241 usd
CY2022Q2 us-gaap Stockholders Equity
StockholdersEquity
-1309444 usd
CY2023Q1 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
51248 usd
CY2022Q2 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
51148 usd
CY2023Q1 us-gaap Revenues
Revenues
30592 usd
CY2022Q1 us-gaap Revenues
Revenues
0 usd
us-gaap Revenues
Revenues
30592 usd
us-gaap Revenues
Revenues
0 usd
CY2023Q1 us-gaap Labor And Related Expense
LaborAndRelatedExpense
12205 usd
CY2022Q1 us-gaap Labor And Related Expense
LaborAndRelatedExpense
29640 usd
us-gaap Operating Income Loss
OperatingIncomeLoss
-192676 usd
us-gaap Operating Income Loss
OperatingIncomeLoss
-207535 usd
CY2023Q1 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
0 usd
CY2022Q1 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
0 usd
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
0 usd
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
0 usd
CY2023Q1 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-29050 usd
CY2022Q1 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-47144 usd
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-192676 usd
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-207535 usd
CY2023Q1 us-gaap Net Income Loss Attributable To Noncontrolling Interest
NetIncomeLossAttributableToNoncontrollingInterest
-1965 usd
CY2022Q1 us-gaap Net Income Loss Attributable To Noncontrolling Interest
NetIncomeLossAttributableToNoncontrollingInterest
0 usd
us-gaap Net Income Loss Attributable To Noncontrolling Interest
NetIncomeLossAttributableToNoncontrollingInterest
-1965 usd
us-gaap Net Income Loss Attributable To Noncontrolling Interest
NetIncomeLossAttributableToNoncontrollingInterest
0 usd
CY2023Q1 us-gaap Profit Loss
ProfitLoss
-27085 usd
CY2022Q1 us-gaap Profit Loss
ProfitLoss
-47144 usd
us-gaap Profit Loss
ProfitLoss
-190711 usd
us-gaap Profit Loss
ProfitLoss
-207535 usd
CY2023Q1 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
61253 usd
CY2022Q1 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
5928 usd
us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
57879 usd
us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
-18304 usd
CY2023Q1 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
34168 usd
CY2022Q1 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-41216 usd
us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-132832 usd
us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-225839 usd
CY2023Q1 token Net Income Loss Per Shares Basic And Diluted
NetIncomeLossPerSharesBasicAndDiluted
0
CY2022Q1 token Net Income Loss Per Shares Basic And Diluted
NetIncomeLossPerSharesBasicAndDiluted
0
token Net Income Loss Per Shares Basic And Diluted
NetIncomeLossPerSharesBasicAndDiluted
0
token Net Income Loss Per Shares Basic And Diluted
NetIncomeLossPerSharesBasicAndDiluted
0
CY2023Q1 token Weighted Average Number Of Shares Outstanding Basic And Diluted
WeightedAverageNumberOfSharesOutstandingBasicAndDiluted
2095872947 shares
CY2022Q1 token Weighted Average Number Of Shares Outstanding Basic And Diluted
WeightedAverageNumberOfSharesOutstandingBasicAndDiluted
2095872947 shares
token Weighted Average Number Of Shares Outstanding Basic And Diluted
WeightedAverageNumberOfSharesOutstandingBasicAndDiluted
2095872947 shares
token Weighted Average Number Of Shares Outstanding Basic And Diluted
WeightedAverageNumberOfSharesOutstandingBasicAndDiluted
2095872947 shares
CY2021Q2 us-gaap Stockholders Equity
StockholdersEquity
-1028756 usd
token Foreign Currency Translation Gain Amount
ForeignCurrencyTranslationGainAmount
-16491 usd
token Net Income For The Period
NetIncomeForThePeriod
-160391 usd
CY2022Q1 us-gaap Stockholders Equity
StockholdersEquity
-1205638 usd
CY2022Q2 us-gaap Stockholders Equity
StockholdersEquity
-1309444 usd
token Foreign Currency Translation Gain Amount
ForeignCurrencyTranslationGainAmount
-3374 usd
token Net Income For The Period
NetIncomeForThePeriod
-163626 usd
CY2022Q4 us-gaap Stockholders Equity
StockholdersEquity
-1476444 usd
CY2023Q1 token Foreign Currency Translation Gain Amount
ForeignCurrencyTranslationGainAmount
61253 usd
CY2023Q1 token Net Income For The Period
NetIncomeForThePeriod
-29050 usd
CY2023Q1 us-gaap Stockholders Equity
StockholdersEquity
-1444241 usd
us-gaap Net Income Loss
NetIncomeLoss
-192676 usd
us-gaap Net Income Loss
NetIncomeLoss
-207535 usd
us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
12205 usd
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-180471 usd
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-207535 usd
us-gaap Payments To Acquire Other Productive Assets
PaymentsToAcquireOtherProductiveAssets
0 usd
us-gaap Payments To Acquire Other Productive Assets
PaymentsToAcquireOtherProductiveAssets
0 usd
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
0 usd
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
0 usd
us-gaap Proceeds From Repayments Of Related Party Debt
ProceedsFromRepaymentsOfRelatedPartyDebt
122692 usd
us-gaap Proceeds From Repayments Of Related Party Debt
ProceedsFromRepaymentsOfRelatedPartyDebt
225839 usd
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
122692 usd
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
225839 usd
us-gaap Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
57879 usd
us-gaap Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
-18304 usd
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
100 usd
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
0 usd
CY2022Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
312 usd
CY2021Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
312 usd
CY2023Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
412 usd
CY2022Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
312 usd
CY2018Q1 us-gaap Treasury Stock Common Shares
TreasuryStockCommonShares
19266000 shares
CY2018Q1 token Equity Method Investments Ownership Percentage
EquityMethodInvestmentsOwnershipPercentage
1 pure
token Number Of Shares Outstanding Prior To Merger
NumberOfSharesOutstandingPriorToMerger
116466000 shares
CY2023Q1 token Surrender Stockholder Shares
SurrenderStockholderShares
19266000 shares
CY2020Q3 token Stock Cancelled During Period Shares Acquisitions
StockCancelledDuringPeriodSharesAcquisitions
174540600 shares
CY2023Q1 us-gaap Notes Issued1
NotesIssued1
225000 usd
token Foreign Currency Translationtabletextblock
ForeignCurrencyTranslationtabletextblock
<table cellpadding="0" style="border-spacing:0;text-align:left;font:10pt times new roman;width:100%"><tbody><tr style="height:15px"><td><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="hdcell" colspan="2" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:center;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>March 31, 2023</strong></p></td><td style="PADDING-BOTTOM: 1px;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="hdcell" colspan="2" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:center;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>March 31, 2022</strong></p></td><td style="PADDING-BOTTOM: 1px;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">Period end: GBP to USD exchange rate</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">1.23</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">1.37</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px;background-color:#ffffff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">Average period: GBP to USD exchange rate</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">1.21</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">1.31</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr></tbody></table>
CY2023Q1 us-gaap Derivative Forward Exchange Rate1
DerivativeForwardExchangeRate1
1.23 pure
us-gaap Use Of Estimates
UseOfEstimates
<p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">The preparation of CFS in conformity with U.S. GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the CFS and the reported amounts of revenues and expenses during the reporting period. The Company regularly evaluates estimates and assumptions. The Company bases its estimates and assumptions on current facts, historical experience and various other factors that it believes to be reasonable under the circumstances, the results of which form the basis for making judgments about the carrying values of assets and liabilities and the accrual of costs and expenses that are not readily apparent from other sources. The actual results experienced by the Company may differ materially and adversely from the Company’s estimates. To the extent there are material differences between the estimates and the actual results, future results of operations will be affected.</p>
CY2018Q3 token Agreement To Purchase Percentage
AgreementToPurchasePercentage
0.75 pure
CY2019Q2 token Acquisition And Exchange Agreement Description
AcquisitionAndExchangeAgreementDescription
the Company executed an Acquisition and Exchange Agreement with Lalit Kumar Verma and Manickam Mahalingam, who together control 100% of the common shares of ABT Auto Investments Ltd., a private English company. Pursuant to the Agreement, Messrs. Verma and Mahalingam were to exchange 96,001 shares, representing 100% of the common shares of ABT Auto Investments Ltd for a total of 3,530,000,000 new issue treasury shares issued by the Company, representing 95% ownership of the Company. On June 20, 2019, the Company executed a Mutual Rescission and Release Agreement, mutually rescinding the Acquisition and Exchange Agreement with Fortress Ventures LLC represented by Lalit Kumar Verma and with ABT Investments India Pvt Ltd represented by Manickam Mahalingam. The Mutual Rescission and Release agreement executed and became effective as of June 20, 2019. As a consequence of its execution and the rescinding of the Share Exchange and Acquisition Agreement, the Company will not issue the 3,530,000,000 shares of common stock

Files In Submission

Name View Source Status
0001477932-23-004157-index-headers.html Edgar Link pending
0001477932-23-004157-index.html Edgar Link pending
0001477932-23-004157.txt Edgar Link pending
0001477932-23-004157-xbrl.zip Edgar Link pending
Financial_Report.xlsx Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R3.htm Edgar Link pending
R4.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending
token-20230331.xsd Edgar Link pending
token_10q.htm Edgar Link pending
token_ex311.htm Edgar Link pending
token_ex312.htm Edgar Link pending
token_ex321.htm Edgar Link pending
token-20230331_lab.xml Edgar Link unprocessable
token-20230331_pre.xml Edgar Link unprocessable
token-20230331_def.xml Edgar Link unprocessable
FilingSummary.xml Edgar Link unprocessable
token-20230331_cal.xml Edgar Link unprocessable
token_10q_htm.xml Edgar Link completed